Democrats in Congress and health advocates say the proposed rule would eliminate one of the few impediments to sky-high drug prices in the United States. The Pharmaceutical Research and Manufacturers of America, an industry trade group, has not yet submitted a comment on the proposed rule. ADADLiberal Democrats in Congress are pushing the Biden administration to reject the Trump rule. The Trump rule would apply to all government-backed inventions, but the focus of the public debate generally has been over drugs. The association maintains that advocates of lower drug prices concocted “hidden meaning” in the Bayh-Dole march-in rights that needs to be definitively ruled out.

Source: Washington Post March 31, 2021 10:02 UTC